“EXPLORATION OF HYDROXYL SUBSTITUTED REGORAFENIB DERIVATIVES AS A TYROSINE KINASE INHIBITORS OF LEUKIMIA THROUGH MOLECULAR DOCKING”. Frontier in Medical and Health Research, vol. 4, no. 3, Mar. 2026, pp. 3863-74, https://fmhr.net/index.php/fmhr/article/view/3740.